4322 J . Org. Chem., Vol. 64, No. 12, 1999
Carpino and Philbin
2-(P h en ylsu lfon yl)-2-pr open yl-N-p-ch lor oan ilin e. A neat
sample of solid 2-(phenylsulfonyl)-2-propenyl N-(p-chlorophen-
yl)carbamate, mp 104-106 °C, was stored in an ordinary vial
at room temperature. After about 1 year it was noted that the
melting point was lower (mp 69-73 °C). The sample was
recrystallized from 70% CCl4/Skelly B which gave the allyl-
amine, mp 76.5-77.0 °C; IR (KBr) 3400, 1590, 1500, 1440,
1300, 1260, 1170, 1070, 970, 820, 750, 720, 680 cm-1; 1H NMR
(CDCl3) δ 3.97 (s, 2), 4.12 (bs, 1), 5.93 (s, 1), 6.41 (s, 1), 6.25-
7.02 (m, 4), 7.54-7.92 (m, 5); 13C NMR (CDCl3) δ 147.8, 145.6,
139.4, 134.6, 130.1, 129.7, 128.8, 125.5, 123.5, 114.5, 43.8.
Anal. Calcd for C15H14ClNO2S: C, 58.53; H, 4.58; N, 4.55.
Found: C, 58.27; H, 4.65; N, 4.57.
2-(ter t-Bu tylsu lfon yl)-2-p r op en yloxyca r bon ylp h en yl-
a la n yl Ch lor id e. To a stirred solution of 2.50 g (6.77 mmol)
of 2-(tert-butylsulfonyl)-2-propenyloxycarbonylphenylalanine
in 15 mL of dry DCM was added dropwise under a nitrogen
atmosphere a solution of 4.9 mL (10 equiv) of thionyl chloride
in 10 mL of dry DCM. Upon completion of the addition, the
solution was refluxed for 2 h. The solution was cooled to room
temperature, and excess thionyl chloride and solvent were
removed under reduced pressure with the aid of a vacuum
pump. The crude residue was recrystallized from 30 mL of 33%
DCM/pentane to give 2.13 g (82%) of the acid chloride, mp
100.0-100.5 °C; IR (KBr) 3400, 1810, 1790, 1720, 1510, 1295,
1250, 1105, 760, 710, 630 cm-1; 1H NMR (CDCl3) δ 1.38 (s, 9),
3.27 (m, 2), 4.88 (m, 3), 5.27 (d, 1), 6.10 (s, 1), 6.27 (s, 1), 7.15-
7.45 (m, 5); [R] +15.3° (c ) 1, CH2Cl2); [R] +18.7° (c ) 1, CH2-
Cl2). Anal. Calcd for C17H22ClNO5S: C, 52.64; H, 5.72; N, 3.61.
Found: C, 52.32; H, 5.39; N, 3.55.
ter t-Bu t yl 2-(ter t-Bu t ylsu lfon yl)-2-p r op en ylp h en yl-
a la n ylp h en yla la n in a te (34). A mixture of 300 mg (0.524
mmol) of tert-butyl 2-(tert-butylsulfonyl)-2-propenyloxycarbo-
nylphenylalanylphenylalaninate and 52 mg (0.1 equiv) of
aminomethylpiperidinyl silica gel in 5 mL of DCM was allowed
to stand for 4 days. The silica gel was filtered and the solvent
removed in vacuo from a water bath at 45 °C. The residue was
recrystallized from Skelly B to give 210 mg (84%) of the
colorless dipeptide derivative, mp 105.0-106.0 °C; IR (KBr)
2-(ter t-Bu tylsu lfon yl)-2-p r op en yloxyca r bon yl Glycin e.
A mixture of 3.34 g (13.9 mmol) of 2-(tert-butylsulfonyl)-2-
propenyl chloroformate and 2.95 g (13.8 mmol) of tert-butyl
glycinate hydrophosphite in 85 mL of DCM was stirred in the
presence of 100 mL of 5% NaHCO3 at room temperature for 4
h. Workup and treatment of the intermediate tert-butyl ester
with TFA in DCM gave an oil which was recrystallized from
30% EtOAc/Skelly B to give 3.25 g (84%) of the acid, mp 105.0-
105.5 °C; IR (KBr) 3355, 1765, 1695, 1560, 1290, 1190, 1100,
1050, 770 cm-1; 1H NMR (CDCl3) δ 1.41 (s, 9), 4.05 (d, 2), 4.94
3360, 3320, 2980, 1730, 1660, 1290, 1150, 1100, 950, 900 cm-1
;
1H NMR (CDCl3) δ 1.28 (s, 9), 1.49 (s, 9), 2.55-3.65 (m, 7),
4.80 (q, 1), 5.85 (s, 1), 6.18 (s, 1), 7.05-7.70 (m, 12); [R] -12.0°
(c ) 1, CHCl3); [R] -13.2° (c ) 1, CHCl3). Anal. Calcd for
C
29H40N2O5S: C, 65.88; H, 7.63; N, 5.30. Found: C, 65.66; H,
(s, 2), 5.44 (t, 1), 6.26 (s, 1), 6.33 (s, 1). Anal. Calcd for C10H17
-
7.42; N, 5.27.
NO6S: C, 43.00; H, 6.13; N, 5.01. Found: C, 43.00; H, 6.03;
N, 4.97.
N-[2-(ter t-Bu t ylsu lfon yl)-2-p r op en yloxy]su ccin im id e
(32). To a stirred solution of 0.25 g (2.17 mmol) of N-
hydroxysuccinimide and 300 µL (2.15 mmol) of triethylamine
in 14 mL of dioxane was added 0.523 g (2.17 mmol) of 2-(tert-
butylsulfonyl)-2-propenyl chloroformate. A precipitate sepa-
rated immediately. The mixture was stirred for 3.5 h, filtered,
and washed with 10 mL of dioxane. The solvent was removed
in vacuo to give a white solid which was recrystallized from
40% EtOAc/Skelly B to give 0.58 g (97%) of the oxysuccinimide,
mp 159-161 °C; IR (KBr) 2980, 1730, 1480, 1450, 1380, 1295,
2-(ter t-Bu t ylsu lfon yl)-2-p r op en yloxyca r b on yl Glycyl
Ch lor id e. Obtained in 91% yield as described for the phenyl-
alanine analogue, mp 61.5-62.5 °C; IR (KBr) 3400, 1800, 1740,
1510, 1280, 1100, 1050, 945, 790, 750, 625 cm-1 1H NMR
;
(CDCl3) δ 1.41 (s, 9), 4.39 (d, 2), 4.95 (s, 2), 5.57 (bs, 1), 6.25
(s, 1), 6.35 (s, 1). Anal. Calcd for C10H16ClNO5S: C, 40.34; H,
5.42; N, 4.70. Found: C, 40.51; H, 5.30; N, 4.83.
Byp r od u ct F or m a tion d u r in g th e P r ep a r a tion of ter t-
Bu tyl 2-(ter t-Bu tylsu lfon yl)-2-pr open yloxycar bon ylph en -
yla la n ylp h en yla la n in a te. A solution of 51.5 mg (0.129
mmol) of 2-(tert-butylsulfonyl)-2-propenyloxycarbonylphenyl-
alanyl chloride and 39.4 mg (0.130 mmol) of tert-butyl phenyl-
alaninate hydrophosphite in 10 mL of DCM was stirred with
20 mL of saturated NaHCO3 at room temperature for 10 min.
The aqueous phase was separated, and the organic layer was
washed with two 20-mL portions of saturated NaHCO3 and
two 20-mL portions of 5% HCl. The organic layer was dried
over MgSO4 and filtered, and the solvent was removed in vacuo
from a water bath at 45 °C. The crude residue was injected
for HPLC analysis. Analysis was carried out on a Waters
Radial Pak 10-µm C18 reverse phase column (0.8 × 10 cm)
under the following conditions: 58% methanol in 0.1% tri-
fluoroacetic acid/water as the mobile phase, flow rate 2 mL/
min, injection volume 5-10 µL, detector 254 nm, attenuation
0.05. Four peaks were observed having retention times of 3.1,
4.1, 9.2, and 19.6 min. These peaks were assigned to residual
Bspoc-Phe-OH (1.9%), 33 (2.1%), 34 (0.3%), and the desired
dipeptide ester (94.3%), respectively.
La ck of Byp r od u ct F or m a tion d u r in g th e Deblock in g
of ter t-Bu tyl 2-(ter t-Bu tylsu lfon yl)-2-p r op en yloxyca r bo-
n ylp h en yla la n ylp h en yla la n in a te by Mea n s of 4-(a m i-
n om eth yl)p ip er id in e (4-AMP ) Silica Rea gen t (35). A
mixture of 25 mg of Bspoc-Phe-Phe-O-t-Bu and 0.436 g (10
equiv) of 4-AMP silica reagent 35 in 2 mL of DCM was stirred
for 15 min. The mixture was filtered and injected for HPLC
analysis which was carried out on a Waters Radial Pak 10-
µm C18 reverse phase column (0.8 × 10 cm) under the following
conditions: 58% methanol in 0.1% trifluoroacetic acid/water
as the mobile phase, flow rate 2 mL/min, injection volume
5-10 µL, detector 254 nm, attenuation 0.05. The free dipeptide
was formed in 95% purity with no detectable contamination
by 34 (<0.1%).
1200, 1110, 1000, 910, 830, 810, 750, 640 cm-1 1H NMR
;
(CDCl3) δ 1.3 (s, 9), 2.7 (s, 4), 4.8 (s, 2), 6.55 (s, 1), 6.7 (s, 1).
Anal. Calcd for C11H17NO5S: C, 47.99; H, 6.22; N, 5.09.
Found: C, 48.22; H, 6.29; N, 5.17.
ter t-Bu tyl 2-(ter t-Bu tylsu lfon yl)-2-p r op en yloxyca r bo-
n ylp h en yla la n in a te. To a stirred solution of 0.185 g (0.768
mmol) of 2-(tert-butylsulfonyl)-2-propenyl chloroformate in 2
mL of benzene at 0 °C was added dropwise a solution of 0.34
g (1.53 mmol) of tert-butyl phenylalaninate in 5 mL of benzene.
Upon addition, a white precipitate began to separate. The
slurry was stirred at room temperature for 30 min, poured
into 15 mL of ether, and washed with three 15-mL portions of
5% HCl, and 15 mL of water. The organic layer was dried over
MgSO4 and filtered, and the solvent was removed in vacuo
from a water bath at 45 °C. The resulting oil was recrystallized
from 20% ether/pentane to give 0.23 g (70%) of the colorless
ester, mp 67-69 °C; IR (KBr) 3410, 2980, 1715, 1510, 1365,
1290, 1155, 1095, 1060, 940, 750, 700, 625 cm-1 1H NMR
;
(CDCl3) δ 1.45 (s, 9), 1.50 (s, 9), 3.12 (m, 2), 4.56 (q, 1), 4.90 (s,
2), 5.38 (d, 1), 6.14 (s, 1), 6.29 (s, 1), 7.15-7.40 (m, 5); [R] +25.4°
(c ) 1, CH2Cl2); [R] +30.9° (c ) 1, CH2Cl2). Anal. Calcd for
C
21H31NO6S: C, 59.27; H, 7.34; N, 3.29. Found: C, 59.31; H,
7.45; N, 3.23.
2-(ter t-Bu tylsu lfon yl)-2-p r op en yloxyca r bon ylp h en yl-
a la n in e. A solution of 18.6 mmol of tert-butyl 2-(tert-butyl-
sulfonyl)-2-propenyloxycarbonylphenylalaninate in 36 mL of
50% DCM/TFA was stirred at room temperature for 2 h.
Excess TFA and solvent were removed in vacuo from a water
bath at 45 °C. The resulting oil was recrystallized from 40%
ether/Skelly B to give 6.35 g (91%) of the colorless acid, mp
88.0-89.5 °C; IR (KBr) 3270, 1760, 1690, 1520, 1290, 1200,
1
1100, 1060, 960, 755, 700, 630 cm-1; H NMR (CDCl3) δ 1.40
(s, 9), 3.20 (m, 2), 4.75 (q, 1), 4.90 (s, 2), 5.35 (d, 1), 6.15 (s, 1),
6.32 (s, 1), 7.15-7.40 (m, 5); [R] -31.0° (c ) 0.5, DMF); [R]
-37.5° (c ) 0.5, DMF). Anal. Calcd for C17H23NO6S: C, 55.27;
H, 6.27; N, 3.79. Found: C, 55.02; H, 6.47; N, 3.71.
Con tin u ou s Solu tion Assem bly of F m oc-Tyr (Bn )-Gly-
Gly-P h e-Leu -OBn (37). A solution of 0.42 g (1.08 mmol) of
Bspoc-Phe-Cl and 0.42 g (1.07 mmol) of H-Leu-OBn‚HOTs in